Literature DB >> 15649993

In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.

Andrea Giacometti1, Oscar Cirioni, Wojciech Kamysz, Giuseppina D'Amato, Carmela Silvestri, Maria Simona Del Prete, Alberto Licci, Jerzy Lukasiak, Giorgio Scalise.   

Abstract

OBJECTIVE: To study the in vitro activity of temporin A, a basic, highly hydrophobic, antimicrobial peptide amide derived from the skin of the European red frog Rana temporaria, alone and in combination with co-amoxiclav, imipenem, ciprofloxacin, linezolid and vancomycin, against 42 nosocomial isolates of Enterococcus faecalis. Fourteen of these were resistant to vancomycin.
METHODS: Antimicrobial activity of temporin A was measured by MIC, MBC and time-kill studies and by the chequerboard titration method.
RESULTS: All isolates were inhibited at concentrations of 1 to 16 mg/L. Combination studies carried out with E. faecalis ATCC 29212 and ATCC 51299 demonstrated synergy only when the peptide was combined with co-amoxiclav and imipenem.
CONCLUSIONS: Our findings show that temporin A is active against E. faecalis and that its activity could be enhanced when it is combined with other antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649993     DOI: 10.1093/jac/dkh545

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection.

Authors:  C Silvestri; O Cirioni; D Arzeni; R Ghiselli; O Simonetti; F Orlando; G Ganzetti; S Staffolani; L Brescini; M Provinciali; A Offidani; M Guerrieri; A Giacometti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-11       Impact factor: 3.267

2.  Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii.

Authors:  Chun-Hsien Lin; Mong-Chuan Lee; Jason T C Tzen; Hsien-Ming Lee; Sam-Min Chang; Wu-Chun Tu; Chuen-Fu Lin
Journal:  Saudi J Biol Sci       Date:  2016-12-23       Impact factor: 4.219

Review 3.  Antibiotic resistance breakers: current approaches and future directions.

Authors:  Mark Laws; Ali Shaaban; Khondaker Miraz Rahman
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

Review 4.  Antimicrobial Peptides and Proteins: From Nature's Reservoir to the Laboratory and Beyond.

Authors:  Tanumoy Sarkar; Monikha Chetia; Sunanda Chatterjee
Journal:  Front Chem       Date:  2021-06-18       Impact factor: 5.221

Review 5.  Design, Engineering and Discovery of Novel α-Helical and β-Boomerang Antimicrobial Peptides against Drug Resistant Bacteria.

Authors:  Surajit Bhattacharjya; Suzana K Straus
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

6.  Functional Characterization of Temporin-SHe, a New Broad-Spectrum Antibacterial and Leishmanicidal Temporin-SH Paralog from the Sahara Frog (Pelophylax saharicus).

Authors:  Sonia André; Zahid Raja; Vincent Humblot; Christophe Piesse; Thierry Foulon; Denis Sereno; Bruno Oury; Ali Ladram
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.